← Home / PSYENCE BIOMEDICAL LTD. (PBM)
Stock Analysis

PSYENCE BIOMEDICAL LTD. (PBM)

PBM
PBM · Healthcare • Biotechnology
4.32 +1.05%
Track PBM in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when PBM price is:
52W Range Position
1%
LOWMIDHIGH
Trend
Mixed
Momentum
Neutral
Updated: 2026-08-26 21:18 UTC
WOI Investment Thesis
Mixed
Current market structure would strengthen above 4.82. Holding above 3.83 preserves the current price structure.
⚖️
✓
Fundamentals
Negative / Pressured / Strong
✓
Price Structure
Mixed
•
Momentum
Neutral
×
Current Resistance
Below Resistance
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
3.83
↗
Break Above
No setup-specific trigger is available; nearest structural resistance is shown.
4.82
🎯
Next Objective
No defined objective is currently available for the primary technical setup.
Not available
×
Thesis Break
No setup-specific invalidation level is currently defined.
Not available
What's Driving PBM?
• No active technical setup
Momentum is Neutral. No qualified technical setup is currently active.
◆ Business quality is mixed
Profitability is negative. Cash generation is pressured. Balance-sheet quality is strong.
⚠️ Key risk remains
Below 3.83
Full Analysis Workspace
Technical Signal
No Active Technical Setup
•
No qualified technical setup is currently active.
RSI(14)
64.2
◎
How to read this setup
From a roadmap perspective, the setup is boxed by support near 3.83 and resistance around 4.82. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis.
Price Chart
PBM — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-08-25
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$2.6M
Company size
EV
$8.7M
Debt-adjusted value
P/E
2.6
Low multiple
P/B
0.2
Low book multiple
P/FCF
-0.5
Not meaningful
Not financial advice
Business Lens
Financial context is mixed
Financial conditions require selective monitoring.
↗
Revenue Growth
Mixed
●
Profitability
Negative
≈
Cash Flow
Pressured
⚖
Balance Sheet
Strong
📈 Net Income
-753,254
↘ Negative
🧮 EPS (Basic)
-0.51
↘ Negative
PSYENCE BIOMEDICAL LTD.
Healthcare • Biotechnology
You Might Also Like